Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Jak2
REST API REST API
Mus musculus
Jak2 is differentially expressed in 251 experiments: 108 organism parts: liver, spleen, ... (106 more);, 14 disease states: normal, 3-NP-induced neurodegeneration model of Huntington's disease, ... (12 more);, 71 cell types 19 cell lines 33 compound treatments and 43 other conditions.
Synonyms 'C81284'
Orthologs F1NQU4_CHICK (Gallus gallus)   Jak2 (Rattus norvegicus)   E1BCP6_BOVIN (Bos taurus)   JAK2 (Homo sapiens)   Q4H3A3_CIOIN (Ciona intestinalis)   PR2 (Drosophila melanogaster)   jak2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term cytosol, response to antibiotic, response to oxidative stress, positive regulation of nitric oxide biosynthetic process, elevation of cytosolic calcium ion concentration, protein binding, SH2 domain binding, cytokine-mediated signaling pathway, cytoplasm, histone binding, positive regulation of cell proliferation, membrane, hormone-mediated signaling pathway, G-protein coupled receptor protein signaling pathway, protein tyrosine kinase activity, receptor binding, insulin receptor substrate binding, negative regulation of heart contraction, nuclear matrix, heme binding, membrane fraction, positive regulation of apoptosis, positive regulation of phosphoprotein phosphatase activity, activation of MAPKK activity, ATP binding, protein kinase binding, nucleus, protein serine/threonine kinase activity, acetylcholine receptor binding, JAK-STAT cascade, non-membrane spanning protein tyrosine kinase activity, protein kinase activity, intracellular protein kinase cascade, positive regulation of cell-substrate adhesion, tumor necrosis factor-mediated signaling pathway, mineralocorticoid receptor signaling pathway, response to hydroperoxide, neuroprotection, negative regulation of cell-cell adhesion, response to tumor necrosis factor, positive regulation of protein import into nucleus, translocation, histone kinase activity (H3-Y41 specific), axon regeneration, platelet-derived growth factor receptor signaling pathway, positive regulation of DNA binding, growth hormone receptor binding, positive regulation of cell migration, histone H3-Y41 phosphorylation, positive regulation of insulin secretion, tyrosine phosphorylation of Stat1 protein, positive regulation of cell differentiation, growth hormone receptor signaling pathway, positive regulation of inflammatory response, induction of apoptosis by oxidative stress, regulation of inflammatory response, response to interleukin-12, positive regulation of interleukin-1 beta production, positive regulation of cell activation, peptide hormone receptor binding, tyrosine phosphorylation of Stat3 protein, protein autophosphorylation, protein phosphorylation, interferon-gamma-mediated signaling pathway, interleukin-12-mediated signaling pathway, phosphatidylinositol 3-kinase binding, positive regulation of sequence-specific DNA binding transcription factor activity
InterPro Term SH2, Band_41_domain, Tyr_kinase_non-rcpt_Jak/Tyk2, Tyr_kinase_non-rcpt_Jak2, Ser/Thr_kinase_dom, Tyr_kinase_cat_dom, Ser-Thr/Tyr_kinase, Se/Thr_kinase-like_dom
Search EB-eye ENSMUSG00000024789
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-20160, E-GEOD-3963, E-GEOD-2866, E-MEXP-1636, ... (62 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17112, E-GEOD-21515, E-GEOD-19732, E-GEOD-10246, E-MEXP-2554, ... (6 experiments)

Factor Value U/D Experiments
Bruce4_p13
1
1
E-GEOD-10246
Swiss2
1
E-GEOD-19732
lewis lung carcinoma (LLC)
1
E-GEOD-17112
IP36D-3
1
E-GEOD-21515
4T1
1
E-GEOD-11259
ESC2
1
E-GEOD-21515
13 more value(s).


Cell type

studied in E-GEOD-2585, E-GEOD-7069, E-GEOD-7764, E-GEOD-13, E-GEOD-21749, ... (28 experiments)

Factor Value U/D Experiments
embryonic stem cell
3
E-GEOD-7069, E-GEOD-21515, E-MEXP-1158
pre-neoplastic cell
1
E-GEOD-2426
granulocyte-macrophage progenitor
1
E-MEXP-2072
LGMP derived from Hoxa9/Meis1a transduced GMP
1
E-GEOD-20377
R1 mouse embryonic stem cells stably transfected with Pcl2 shRNA sequence
1
E-GEOD-16364
intermediolateral column motoneuron
1
E-GEOD-2595
65 more value(s).


Disease state

studied in E-MEXP-1296, E-GEOD-21902, E-GEOD-21543, E-MEXP-1137, E-GEOD-2528, ... (10 experiments)

Factor Value U/D Experiments
breast carcinoma
1
E-GEOD-2528
high grade prostatic intraepithelial neoplasia
1
E-MEXP-1296
bronchoalveolar adenocarcinoma
1
E-MEXP-1137
mPIN (mouse prostatic intraepithelial neoplasia)
1
E-GEOD-21543
non-infected cells
1
E-MEXP-667
dystrophic
1
E-MEXP-1623
8 more value(s).


Compound treatment

studied in E-GEOD-21711, E-TABM-903, E-GEOD-6085, E-GEOD-5041, E-GEOD-4671, ... (28 experiments)

Factor Value U/D Experiments
cardiotoxin
3
E-MEXP-703, E-GEOD-469, E-GEOD-5304
control medium
1
E-GEOD-21711
neuromedin U
1
E-GEOD-1791
AFB1
1
E-MEXP-2209
allergen
1
E-GEOD-483
trans-10, cis-12 conjugated linoleic acid
1
E-GEOD-4671
27 more value(s).


Agent

studied in E-GEOD-26086

Factor Value U/D Experiments
not specified
1
1
E-GEOD-26086


Amount to core
studied in E-GEOD-18858

cell population
studied in E-GEOD-26086

Clinical info
studied in E-MEXP-1458

Cohort
studied in E-GEOD-4356

Developmental stage
studied in E-GEOD-5668, E-GEOD-1026, E-MEXP-1853, E-GEOD-5305, E-MTAB-25, ... (20 experiments)

Diet
studied in E-GEOD-16377

Disease staging
studied in E-GEOD-17112

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Fraction
studied in E-TABM-363

Generation
studied in E-GEOD-6527

Genotype
studied in E-GEOD-19684, E-MEXP-939, E-MEXP-1649, E-GEOD-2746, E-MEXP-1587, ... (37 experiments)

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-MEXP-1190, E-GEOD-17049, E-MEXP-1717, E-GEOD-20302, E-MEXP-1942, ... (6 experiments)

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-5901, E-GEOD-5296

Irradiate
studied in E-GEOD-4066

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-3594, E-GEOD-5296

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-13, E-GEOD-2640

Population
studied in E-GEOD-1571

Protocol type
studied in E-GEOD-16192

Replicate
studied in E-GEOD-17112

Rna integrity number
studied in E-GEOD-18858

Route of exposure
studied in E-GEOD-18858

sample preservation
studied in E-GEOD-18858

Sex
studied in E-GEOD-75

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902, E-GEOD-15901

Strain or line
studied in E-GEOD-17936, E-TABM-671, E-MTAB-76, E-TABM-285, E-GEOD-6591, ... (7 experiments)

Transfect
studied in E-GEOD-6487

Treatment
studied in E-GEOD-19401, E-GEOD-21902, E-GEOD-18344, E-GEOD-21841, E-MEXP-1899, ... (7 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858, E-GEOD-4356

Units of amount
studied in E-GEOD-18858

Units of amount of vehicle
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.147 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM